mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.03 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.04 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.34 |
0.04 |